News
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained ...
Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
The FDA has approved Yeztugo for PrEP to reduce the risk of sexually acquired HIV-1 in adults and adolescents weighing at least 35kg.
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...
He affirmed that the new drug "could take the epidemic to the history books," according to Mother Jones.Yeztugo, based on the ...
Like other PrEP drugs, if enough of the medication is present when a person is exposed to HIV, it can prevent the virus from ...
3d
IFLScience on MSNRevolutionary Drug That's “Closest Thing” To HIV Vaccine Gets FDA ApprovalThe Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that has been shown to act as ...
Yeztugo (generic name lenacapavir), which is given by health care workers in clinics, is significantly more effective than the existing oral HIV-prevention drugs, experts said, because it appears ...
The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results